Amylyx Pharmaceuticals (AMLX) Receivables - Other (2022 - 2026)
Amylyx Pharmaceuticals (AMLX) posted quarterly Receivables - Other of $100000.0 for Q1 2026, little changed year-over-year from $100000.0 in Q1 2025, and little changed quarter-over-quarter from $100000.0 in Q4 2025.
Amylyx Pharmaceuticals (AMLX) Receivables - Other (2022 - 2026) Analysis & Trends
Amylyx Pharmaceuticals' Receivables - Other history runs 5 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- In Q1 2026, Receivables - Other changed 0.0% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $100000.0 (changed 0.0% YoY), while the FY2025 annual figure was $100000.0, changed 0.0% from the prior year.
- Receivables - Other for Q1 2026 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
- The five-year high for Receivables - Other was $800000.0 in Q2 2023, with the low at $100000.0 in Q3 2023.
- The 5-year median for Receivables - Other is $100000.0 (2023), against an average of $235714.3.
- The sharpest annual moves came in 2023 and 2024: Receivables - Other changed 0.0% in 2023, then sank 87.5% in 2024.
- Amylyx Pharmaceuticals' Receivables - Other stood at $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then tumbled by 80.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
- Business Quant data shows AMLX's Receivables - Other at $100000.0 in Q1 2026, $100000.0 in Q4 2025, and $100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Amylyx Pharmaceuticals | 4.34 Bn | 4.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 500,000.00 |
| Jun 30, 2026 | 500,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Mar 31, 2024 | 300,000.00 |